EDGAR Filing Documents for 0001144204-17-021133

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001144204-17-021133

Filing Date

2017-04-20

Accepted

2017-04-20 06:31:34

Documents

Period of Report

2017-01-17

Document Format Files

Seq	Description	Document	Type	Size
1	OWNERSHIP DOCUMENT	v464469_4.html	4
1	OWNERSHIP DOCUMENT	v464469_4.xml	4	4540
	Complete submission text file	0001144204-17-021133.txt		6031

Mailing Address 14 WALL ST. SUITE 3D NEW YORK NY 10005

Business Address 14 WALL ST. SUITE 3D NEW YORK NY 10005 212-269-2834

Dipexium Pharmaceuticals, Inc. (Issuer) CIK: 0001497504 (see all company filings)

IRS No.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DIPEXIUM PHARMACEUTICALS, LLC 74 BROAD STREET NEW YORK NY 10004

Business Address

Type: 4 | Act: 34 | File No.: 001-36351 | Film No.: 17771328